Thus, the increased levels of endosome-associated proteins in NPM1-Ins AML cells will probably contribute to the unique biological characteristics of these cells, and these mechanisms may also represent possible therapeutic targets. The gene discussed is NPM1; the disease is acute myeloid leukemia.